FDA Inspection 1270545 — Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.

Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. — FEI 3004944662

The FDA completed an inspection of Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. on April 11, 2025 in Dongyang. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 11, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dongyang (China)